Head and Neck Cancer

HEAD AND NECK CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US

Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Many Immune Checkpoint Inhibitor Combination Therapies Show No Evidence of Drug Synergy

The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
New Therapies on the Horizon for Elderly or Frail Patients With Head and Neck Cancer

A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.

HEAD AND NECK CANCER NEWS

Larotrectinib Bests Standard Care for TRK-Fusion Positive Cancers

February 2, 2023

“One-Stop Shop” Screening Centers May Improve Cancer Detection

January 30, 2023

Turmeric capsules

Turmeric Mouthwash Reduces Severity of Oral Mucositis in Head and Neck Cancer

January 30, 2023

Young women with cancer

Risk of Suicide Highest in the First 6 Months After a Cancer Diagnosis

January 26, 2023

Child with cancer

Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders

January 25, 2023

Next post in Head and Neck Cancer

doctor with older Black patient wearing mask

Outcomes Worse for Black Patients With Head and Neck Cancer in Clinical Trials